Evidence map›Paper›PMID 30527629›Full record

ArticleBiological psychiatry2019

The Influence of Microglial Elimination and Repopulation on Stress Sensitization Induced by Repeated Social Defeat.

Michael D Weber, Daniel B McKim, Anzela Niraula, Kristina G Witcher, Wenyuan Yin, Carly G Sobol, Yufen Wang, Caroline M Sawicki, John F Sheridan, Jonathan P Godbout

Abstract read
In one paragraph

Article in Biological psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Immunity in Rodent Models of Stress.Biological psychiatry · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Polymers · 2024
    Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Michael D WeberDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio; Division of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
Daniel B McKimDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio; Division of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
Anzela NiraulaDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio; Division of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
Kristina G WitcherDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Wenyuan YinDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio; Division of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
Carly G SobolDivision of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
Yufen WangDivision of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
Caroline M SawickiDivision of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio.
John F SheridanDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio; Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio; Division of Biosciences, The Ohio State University College of Dentistry, Columbus, Ohio. Electronic address: Sheridan.1@osu.edu.
Jonathan P GodboutDepartment of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio; Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Jonathan.Godbout@osumc.edu.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Comprehensive Training in Oral &Craniofacial SciencesT32DE014320 · NIDCR · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2001 to 2022
$10.2M
Dynamic Cellular Interactions Associated with Inflammatory Monocyte Accumulation in the Neurovasculature with Social StressR01MH119670 · NIMH · OHIO STATE UNIVERSITY · PI GODBOUT, JONATHAN P, SHERIDAN, JOHN F · 2019 to 2023
$2.6M
Brain region dependent trafficking of myeloid precursor cells in repeated defeat.R01MH097243 · NIMH · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2013 to 2017
$2.2M
Consequences of Age-Related Impairments in the Dynamic Regulation of Active Microglia by AstrocytesR01AG051902 · NIA · OHIO STATE UNIVERSITY · PI GODBOUT, JONATHAN P · 2016 to 2020
$2.1M
Social threat primes myeloid progenitor cells and microglia: role in anxietyR01MH093473 · NIMH · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2012 to 2016
$1.9M
The Role of Reactive Brain Endothelium in Modulating Stress-Induced Immunological and Behavioral ChangesF30DE026075 · NIDCR · OHIO STATE UNIVERSITY · PI SAWICKI, CAROLINE · 2016 to 2020
$184k
Spleen Monocyte Progenitors Promote Recurring AnxietyF31MH109234 · NIMH · OHIO STATE UNIVERSITY · PI MCKIM, DANIEL BOYCE · 2015 to 2017
$46k
NCI NIH HHS P30 CA016058NIA NIH HHS R01 AG051902NIDCR NIH HHS F30 DE026075NIDCR NIH HHS T32 DE014320NIMH NIH HHS F31 MH109234NIMH NIH HHS R01 MH093473NIMH NIH HHS R01 MH097243NIMH NIH HHS R01 MH119670
6 · The paper itself

Abstract

backgroundStress is associated with an increased prevalence of anxiety and depression. Repeated social defeat (RSD) stress in mice increases the release of monocytes from the bone marrow that are recruited to the brain by microglia. These monocytes enhance inflammatory signaling and augment anxiety. Moreover, RSD promotes stress sensitization, in which exposure to acute stress 24 days after cessation of RSD causes anxiety recurrence. The purpose of this study was to determine whether microglia were critical to stress sensitization and exhibited increased reactivity to subsequent acute stress or immune challenge.

methodsMice were exposed to RSD, microglia were eliminated by colony-stimulating factor 1 receptor antagonism (PLX5622) and allowed to repopulate, and responses to acute stress or immune challenge (lipopolysaccharide) were determined 24 days after RSD sensitization.

resultsMicroglia maintained a unique messenger RNA signature 24 days after RSD. Moreover, elimination of RSD-sensitized microglia prevented monocyte accumulation in the brain and blocked anxiety recurrence following acute stress (24 days). When microglia were eliminated prior to RSD and repopulated and mice were subjected to acute stress, there was monocyte accumulation in the brain and anxiety in RSD-sensitized mice. These responses were unaffected by microglial elimination/repopulation. This may be related to neuronal sensitization that persisted 24 days after RSD. Following immune challenge, there was robust microglial reactivity in RSD-sensitized mice associated with prolonged sickness behavior. Here, microglial elimination/repopulation prevented the amplified immune reactivity ex vivo and in vivo in RSD-sensitized mice.

conclusionsMicroglia and neurons remain sensitized weeks after RSD, and only the immune reactivity component of RSD-sensitized microglia was prevented by elimination/repopulation.

Indexed as

Social BehaviorAnimalsBrainCX3C Chemokine Receptor 1Cyclic AMP Response Element-Binding ProteinIllness BehaviorLipopolysaccharidesMaleMiceMice, TransgenicMicrogliaMonocytesOrganic ChemicalsProto-Oncogene Proteins c-fosRNA, MessengerStress, PsychologicalCreb1 protein, mouseCX3C Chemokine Receptor 1Cx3cr1 protein, mouseCyclic AMP Response Element-Binding ProteinLipopolysaccharidesOrganic ChemicalsPLX5622Proto-Oncogene Proteins c-fosRNA, MessengerAnxietyCSF1R antagonistMicrogliaMonocytesRepeated social defeatStress

Identifiers

PMID30527629
PMCPMC6440809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.